AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
Oct 25, 2012
30016_dirs_2012-10-25_78521226-ebb8-446c-9407-da3c6f368f30.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-09-18
Reporting Person: DEADY CONAN R (Corp VP, General Counsel & Sec)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-18 | Common Stock | G | 500 | — | Disposed | 3498 | Direct |
| 2012-09-20 | Common Stock | G | 750 | — | Disposed | 2748 | Direct |
| 2012-10-23 | Common Stock | S | 1566 | $97.2449 | Disposed | 1182 | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $97.1662 to $97.3500, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26